First of all, under the Federal Freedom of Information Act (FOIA), it does not matter who sponsored a study. The question is whether or not the records in question are in the possession of the Agency. In the case of a clinical trial sponsored by NIH but conducted by another entity, I doubt the Agency would have the identities of the subjects. Second, Section 552(b) states that the Act "does not apply to matters that are .... (6) personnel and medical files and similar files the disclosure of which would constitute a clearly unwarranted invasion of personal privacy" Given this language, I doubt that a court would be persuaded to release personal data because somebody thinks it's in the interest of the patients. ----- Original Message ----- From: "[log in to unmask]" <[log in to unmask]> To: <[log in to unmask]> Sent: Sunday, August 27, 2006 1:27 PM Subject: Re: Looking for participants in GDNF trial - can you help? Thanks for your suggestion Bob. Unfortunately the phase II GDNF trial was sponsored by Amgen, not the NIH or another federal agency, so I don't think the Freedom of Information Act would apply, but i'll check on it. Linda -- Bob Allison <[log in to unmask]> wrote: LInda I'm sure you have thought about this already, but wouldn't the names be subject to a Freedom of Info request since the trial was sanctioned by a gov't agency. I assume that Amgen is not providing them due to HIPPA. But has that been challenged in court due to an overriding concern for the benefit of the patient. Bob ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn